MedPath

A clinical trial on effectiveness of Ayurvedic medicines in improving the disease free survival and/or controlling recurrence of disease of breast cancer patients, whose cancer cells are negative for further hormonal treatment using complimentary Ayurvedic treatment.

Phase 2
Conditions
Health Condition 1: null- Health condition â??Breast cancer patients negative for triple receptors, Problem studied â??Early metastasis and rapid growth of cancer due to inability to respond to hormonal therapy.Health Condition 2: C50- Malignant neoplasm of breast
Registration Number
CTRI/2017/01/007690
Lead Sponsor
Dr Vasanti Godse
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Immunohistochemically proved triple negative breast cancer patients of stages I to III, in the age group between 25 and 75 will be included in the study

Exclusion Criteria

Patients with distant metastasis at diagnosis (Stage IV) will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath